Evasc Neurovascular Announces First Neuro Product Approved in French Forfait Innovation Program
Retrieved on:
Tuesday, February 23, 2021
Evasc Neurovascular is proud to announce its successful application to Frances Ministry of Health (Haute Autorit de la Sant, HAS) Forfait Innovation (FI) program for the eCLIPs device, published in its official journal December 23, 2020 - https://www.legifrance.gouv.fr/jorf/id/JORFTEXT000042722732 .
Key Points:
- Evasc Neurovascular is proud to announce its successful application to Frances Ministry of Health (Haute Autorit de la Sant, HAS) Forfait Innovation (FI) program for the eCLIPs device, published in its official journal December 23, 2020 - https://www.legifrance.gouv.fr/jorf/id/JORFTEXT000042722732 .
- View the full release here: https://www.businesswire.com/news/home/20210222005015/en/
The eCLIPs device is the first neuro device that has gained Forfait Innovation approval and funding (Graphic: Business Wire)
The Forfait Innovation program grants clinical trial funding to evaluate CE marked devices that are deemed to be truly innovative (not simply incremental developments) and offer significant clinical benefit, filling an unmet medical need. - The eCLIPs device is the first neuro device that has gained FI approval and funding.
- Evasc Neurovascular is a privately-held medical device company focused on the development of disruptive endovascular treatments for cerebral aneurysms.